Device Trial Radar · NCT01175928
Pneumatic Medicine: A Transformative Treatment for Diabetic Peripheral Neuropathy
Last checked: Nov 20, 2026Latest source record: Apr 20, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
60
Planned (sponsor's estimate)
Start
Oct 2010
Primary completion
Sep 2012
Study completion Sep 2012
Sponsor
- Lead sponsor
- NormaTec Industries LPNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- First posted
- Aug 5, 2010
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy of the NormaTec PCD, a non-invasive pneumatic compression device with the patented peristaltic pulse pneumatic waveform, in the treatment of Diabetic Peripheral Neuropathy (DPN). The study will compare treatment with a NormaTec PCD and a sham device to assess whether the NormaTec PCD improves the signs and symptoms of DPN.
Conditions
- Diabetic Polyneuropathy
Interventions
Sham deviceDevice
Home treatment with PCD to both legs: 2 sessions of 1 hour duration every day
NormaTec PCD (Peristaltic Pulse PCD)Device
Home treatment with PCD to both legs: 2 sessions of 1 hour duration every day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Nerve Conduction StudiesTime frame: 3 months
2 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
NormaTec
Newton Center, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.